Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3.
about
Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adultsStructured treatment interruptions (STI) in chronic suppressed HIV infection in adultsGeneration and characterization of a defective HIV-1 Virus as an immunogen for a therapeutic vaccine.Use of RT-defective HIV virions: new tool to evaluate specific response in chronic asymptomatic HIV-infected individualsA dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication.Structured treatment interruptions with tenofovir monotherapy for simian immunodeficiency virus-infected newborn macaques.Preferential infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivo.A therapeutic dendritic cell-based vaccine for HIV-1 infection.Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection.HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses.Interrupting highly active antiretroviral therapy in patients with HIV.Influence of episodes of intermittent viremia ("blips") on immune responses and viral load rebound in successfully treated HIV-infected patients.HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infectionStandard vaccines increase HIV-1 transcription during antiretroviral therapy.Assessment of migration of HIV-1-loaded dendritic cells labeled with 111In-oxine used as a therapeutic vaccine in HIV-1-infected patients.
P2860
Q24245541-0908AC9C-5945-4892-B376-5473FDCE45B4Q24245709-49DEAF31-711A-42A6-B120-3D2CD9275454Q31106756-F0356D7E-C502-49D7-9F96-9600095D3F05Q34630184-81268A01-262A-4A32-B645-2B9F1126798CQ34646987-5872637A-56C0-4A14-9DFB-CD31A7AD421BQ34716901-EAC8B6FA-F065-4F00-B6C4-53A9EFBE5F20Q34717597-ABBE6D0F-1725-414F-9CBD-6F21C0EDDA58Q34764392-DBF77925-C8D2-41BA-8801-4AA642EE179BQ35175897-CA7D45CC-DC5A-406B-8E21-91B35C370C03Q35973632-FC1E27CA-FCB6-44FB-8EB0-083E0278C539Q36066209-5A3BDC0A-A385-488A-94E3-B992E91B4680Q36509570-76C14B72-174A-4968-9018-567D9C7A2582Q37051649-30ED27A0-88EF-419D-8DDA-E239B5A3CC37Q38840779-A3D6E2AA-7977-4596-97FC-7C8385002EF6Q39984018-A44B1D05-DD9D-409D-B553-3E2D1A3D2244
P2860
Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Relevance of HIV-1-specific CD ...... 4+ T-cell nadir above 400/mm3.
@en
Relevance of HIV-1-specific CD ...... 4+ T-cell nadir above 400/mm3.
@nl
type
label
Relevance of HIV-1-specific CD ...... 4+ T-cell nadir above 400/mm3.
@en
Relevance of HIV-1-specific CD ...... 4+ T-cell nadir above 400/mm3.
@nl
prefLabel
Relevance of HIV-1-specific CD ...... 4+ T-cell nadir above 400/mm3.
@en
Relevance of HIV-1-specific CD ...... 4+ T-cell nadir above 400/mm3.
@nl
P2093
P50
P1476
Relevance of HIV-1-specific CD ...... 4+ T-cell nadir above 400/mm3.
@en
P2093
Anna Cruceta
Anna Lopez
Catherine Fagard
Emilio Fumero
Ferran Segura
Gabriel M Ortiz
Gabriel Mestre
Jose M Gatell
José M Miró
Lucia Lopalcos
P304
P356
10.1097/00126334-200407010-00005
P407
P577
2004-07-01T00:00:00Z